Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133 [Phase 1, Phase 2]
Phase 1/2 trial evaluating CART133 for relapsed/chemo-refractory advanced malignancies completed, across multiple cancers.
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: Fatigue Intervention Trial for Breast Cancer Survivors [Phase 3]
Phase 3 clinical trial update on fatigue intervention for breast cancer survivors; the study has completed.
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: Perillyl Alcohol in Treating Patients With Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial investigating perillyl alcohol for metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: Effect of Cancer Nurse Navigators on Patient Outcomes [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating the impact of cancer nurse navigators on patient outcomes has been terminated.
-
CLINICAL_TRIALS research · 2019-12-13Clinical Trial Update: The Breast Cancer Online Rehabilitation Program [NA]
Clinical trial update for the Breast Cancer Online Rehabilitation Program completed with results posted in 2019.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-12-12Clinical Trial Update: Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer [Phase 2]
Phase 2 trial update of lapatinib for brain metastases in ErbB2-positive breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-12Clinical Trial Update: XELOX for Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial update for XELOX in metastatic breast cancer (completed).
-
CLINICAL_TRIALS trial_result · 2019-12-12Clinical Trial Update: Methods in Education for Breast Cancer Genetics [Phase 3]
A Phase 3 clinical trial update evaluating education methods for genetics in breast cancer and ovarian cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2019-12-11Clinical Trial Update: A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting [Phase 3]
Phase 3 trial comparing neratinib plus capecitabine versus lapatinib plus capecitabine in HER2-positive metastatic breast cancer after multi…
-
CLINICAL_TRIALS trial_result · 2019-12-11Clinical Trial Update: Nab-Paclitaxel in Patients With ER+/HER2- Recurrent Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating nab-paclitaxel in ER+/HER2- recurrent metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast Cancer [Phase 2]
A Phase 2 trial evaluating LY2157299 Monohydrate in combination with radiotherapy for metastatic breast cancer was terminated with results p…
-
CLINICAL_TRIALS trial_result · 2019-12-04Clinical Trial Update: The Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast Cancer [Phase 3]
Phase 3 clinical trial update evaluating BAT8001 injection for efficacy and safety in HER2-positive advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-12-04Clinical Trial Update: Evaluation of Hypertension as a Predictor of Efficacy Bevacizumab in Metastatic Breast Cancer and Colorectal Cancer
A completed clinical trial evaluating whether hypertension predicts efficacy of bevacizumab in metastatic colorectal and breast cancer, with…
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Seroma Reduction After Mastectomy [Phase 4]
Phase 4 clinical trial update examining seroma reduction after mastectomy, completed.
-
CLINICAL_TRIALS trial_result · 2019-12-02Clinical Trial Update: Olaparib Treatment in Relapsed Germline Breast Cancer Susceptibility Gene (BRCA) Mutated Ovarian Cancer Patients Who Have Progressed at Least 6 Months After Last Platinum Treatment and Have Received at Least 2 Prior Platinum Treatments [Phase 3]
Phase 3 trial evaluating olaparib in BRCA-mutated relapsed ovarian cancer after platinum-based therapy; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-12-02Clinical Trial Update: High vs Low Dose Dexamethasone on Complications in the Immediate Postoperative Phase After Mastectomy [Phase 4]
A Phase 4 trial evaluating high vs low dose dexamethasone on postoperative complications after mastectomy; study completed with results post…
-
CLINICAL_TRIALS trial_result · 2019-12-02Clinical Trial Update: Nab-paclitaxel Compared With Docetaxel Followed by Anthracyclines and Cyclophosphamide in the Neoadjuvant Breast Cancer [Phase 4]
Clinical trial update comparing nab-paclitaxel with docetaxel followed by anthracyclines and cyclophosphamide in neoadjuvant breast cancer (…
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: FDHT PET and Bicalutamide in Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating FDHT PET imaging and bicalutamide in metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: A Study to Evaluate Safety, Tolerability and Efficacy of Eribulin Mesylate in Treating Adult Females With Locally Advanced or Metastatic Breast Cancer [Phase 4]
Phase 4 trial updating safety, tolerability and efficacy of eribulin mesylate in adult females with locally advanced or metastatic breast ca…
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: "Curcumin" in Combination With Chemotherapy in Advanced Breast Cancer [Phase 2]
Phase 2 trial evaluating curcumin in combination with chemotherapy for advanced/metastatic breast cancer has completed.
-
CLINICAL_TRIALS withdrawal · 2019-11-26Clinical Trial Update: A Study to Compare Pertuzumab + Trastuzumab + Vinorelbine vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer [Phase 3]
A Phase 3 trial comparing pertuzumab plus trastuzumab with vinorelbine vs placebo plus trastuzumab with docetaxel in previously untreated HE…
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: Denosumab for Breast Cancer With Bone Mets [Phase 2]
Phase 2 clinical trial update for denosumab in breast cancer with bone metastases; trial has been terminated with results posted.
-
FDA approval · 2019-11-21FDA Approved: FASLODEX — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Faslodex (fulvestrant) submitted by AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2019-11-21FDA Approved: FULVESTRANT — Original Application (Meitheal Pharmaceuticals Inc)
FDA approved the original application for a generic Fulvestrant product from Meitheal Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2019-11-18Clinical Trial Update: Efficacy of Preoperative Pectoral Nerve Block for Intraoperative Opioid Sparing Effect and Postoperative Analgesia [NA]
A completed clinical trial evaluating whether preoperative pectoral nerve block reduces intraoperative opioid use and improves postoperative…